Preclinics
German preclinical CRO offering in vivo pharmacology, pharmacokinetic and exploratory safety studies.
82 contract research organizations in our directory list at least one of In Vitro Pharmacology, In Vitro ADME, In Vivo PK, In Vivo Efficacy, Dose-Response Studies, Target Engagement, Metabolite Identification, Formulation Development, Antibody Discovery or Organoid & 3D Models, across 17 countries. 30 report GLP capability and 11 report AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.
Drug discovery CROs help sponsors move from a target and a set of hits to a single development candidate. The biology side of that work, which is what this page covers, runs in a loop with chemistry: in vitro potency and selectivity assays rank compounds, in vitro ADME screens flag metabolic and permeability problems, and in vivo PK and efficacy studies show whether the best compounds reach their target and change disease-relevant endpoints in an animal.
Sponsors choose between integrated discovery CROs, which combine medicinal chemistry with biology, ADME and in vivo pharmacology under one project team, and specialist labs that do one part of the loop very well. Integrated providers shorten hand-offs and suit virtual biotechs without their own labs. Specialists often have deeper experience in a particular disease model, target class or species. Many programs use both. This directory lists labs by their discovery biology, ADME and in vivo capabilities; confirm chemistry capacity directly if you need it.
Whatever the model, agree on the candidate selection criteria before the work starts: the potency, selectivity, exposure and efficacy thresholds a compound must meet, plus early safety flags such as hERG and Ames results. Clear criteria keep the loop focused and make the eventual IND-enabling package faster to scope.
Showing 82 CROs. Order rotates daily so no lab is permanently listed first.
German preclinical CRO offering in vivo pharmacology, pharmacokinetic and exploratory safety studies.
Berlin oncology CRO with a large collection of patient-derived xenograft models for in vivo efficacy and biomarker studies.
Hyderabad-based preclinical CRO offering GLP toxicology, pharmacology and pharmacokinetic studies across rodent and non-rodent species.
Integrated drug discovery CRO in Nottingham with in vivo pharmacology, DMPK and bioanalysis alongside chemistry and biology.
South Korea's first private non-clinical CRO, providing GLP toxicity, safety pharmacology, pharmacokinetic and efficacy studies for drugs, chemicals and biologics.
Texas preclinical CRO offering xenograft and other oncology models, efficacy, pharmacology and toxicology studies.
Korean nonclinical pharmacology CRO in the Biotoxtech group offering efficacy studies, PCR-based biodistribution for cell and gene therapies, and GLP bioanalysis.
Tokyo CRO known for NASH/MASH and fibrosis mouse models, with efficacy studies across liver, kidney and metabolic disease.
Kentucky CRO developing immunodeficient rat and mouse models, offering xenograft efficacy and safety studies in larger rodent hosts.
Preclinical CRO with roots in a Chinese Academy of Sciences safety center, offering pharmacology, DMPK and safety evaluation with GLP operations in Shenzhen.
Vertically integrated nonhuman primate CRO in South Carolina combining on-site breeding with discovery pharmacology, GLP toxicology, vaccine and gene therapy studies.
Danish non-profit research CRO offering customised cell models, assays and translational research services.
Korean nonclinical CRO providing early PK, TK and bioanalytical method development and sample analysis.
Maryland CRO specializing in infectious disease and vaccine research, offering in vitro and in vivo efficacy models and immunological assays.
Contract vivarium operator providing turnkey animal housing, husbandry, veterinary and technical research services for biotech teams, with in vivo study support.
Shanghai CRO centered on nonhuman primate efficacy and safety studies, with NHP disease models across metabolism, cardiovascular, renal, neurology and ophthalmology, clinical-style imaging and interventional surgery.
Chinese provider of genetically engineered mouse models with in vivo pharmacology services across oncology, immunology and metabolic disease.
Finnish preclinical CRO focused on bone and joint disease, bone metastasis and oncology models, including osteoarthritis and osteoporosis efficacy studies.
Translational neuroscience CRO with sites in the UK, Ireland and Canada offering CNS disease models, EEG and behavioral pharmacology.
French CRO specializing in in vivo infection models for antibacterial and antifungal drug development.
Israeli preclinical CRO offering in vivo pharmacology and disease model studies.
ANEWCRO is a nonclinical contract research organization (CRO) dedicated to providing innovative solutions and support to the biopharmaceutical industry, biotech startups and academic institutions. With unlimited access…
AAALAC-accredited Japanese CRO specializing in nonhuman primate disease models for preclinical efficacy and proof of concept.
Hyderabad discovery services company offering biology and DMPK support alongside chemistry.
Minnesota company providing preclinical services and reagents for oncolytic virus, gene and cell therapy programs, including reporter imaging and efficacy models.
Michigan CRO offering in vivo ADME and pharmacokinetics, LC-MS/MS bioanalysis and biochemistry, with a niche in ocular drug development.
Large China-based nonclinical CRO offering GLP safety assessment, pharmacology, pharmacokinetics and bioanalysis, with operations in China and the United States.
National primate research center with high-containment capability supporting infectious disease, vaccine and translational NHP studies, including sponsored research.
Preclinical CRO near Lyon with core expertise in nonhuman primate models, including BSL-3 infectious disease, biodistribution and custom proof-of-concept studies.
Not-for-profit research institute in Birmingham, Alabama providing contract drug discovery and preclinical development, including infectious disease and BSL-3 work, oncology models, ADME, bioanalysis, toxicology and…
Integrated CRO-CDMO in India whose discovery biology group provides in vivo pharmacology, DMPK and bioanalysis for small molecule programs.
Japanese company offering humanized-liver mice and contract studies for human metabolism, DMPK and hepatitis research.
Preclinical efficacy CRO in the Boston area running predictive animal models across inflammation, mucositis, oncology-supportive care and other indications for biotech and pharma sponsors.
Lyon oncology CRO providing in vitro and in vivo proof-of-concept studies for anticancer agents, including resistant tumor models.
Polish drug discovery CRO providing integrated chemistry, biology, DMPK and translational research services.
French neuroscience CRO dedicated to in vitro and in vivo models of neurodegenerative and neurological disease, with a US office.
German CRO offering integrated discovery, DMPK, bioanalysis and early development services across sites in Germany and France.
Danish preclinical CRO and peptide discovery company known for metabolic, liver and kidney disease models with AI-supported histology and 3D imaging readouts.
Preclinical CRO in the Research Triangle specializing in ophthalmic disease models, ocular dosing and retinal function readouts.
Bengaluru preclinical CRO providing pharmacology, pharmacokinetic and toxicology studies.
Specialty CRO focused on preclinical kidney disease models and renal pathology for nephrology drug programs.
Ophthalmology-focused preclinical CRO offering retinal and anterior segment disease models, ocular dosing and functional readouts.
European CDMO and CRO offering bioanalysis alongside drug substance, drug product and formulation development.
French CRO focused on neurodegeneration and brain aging, offering in vivo models and readouts for Alzheimer's and related diseases.
Beijing-based company providing genetically engineered and humanized mouse models with in vivo pharmacology services, especially for oncology and immunology antibody programs.
Small niche oncology pharmacology CRO validating in vivo efficacy of cancer therapies in clinically predictive models.
Animal model company offering custom genetically engineered rodents together with in vivo pharmacology and AAV services, with operations in the US and China.
Preclinical CRO near Toulouse specializing in metabolic disease pharmacology, including obesity, diabetes and NASH/MASH models.
Preclinical pharmacology CRO in Shanghai with specialty efficacy models in autoimmunity, inflammation, bone and orthopedics, oncology and metabolic disease, plus supporting PK/PD and exploratory toxicology.
Lyon-based company creating genetically engineered and humanized rodent models, with catalog models and in vivo research services.
Shanghai provider of genetically engineered rodent models with phenotyping and in vivo pharmacology services.
Preclinical CRO focused on rodent models of autoimmune and inflammatory disease, such as EAE, arthritis and colitis, with supporting histology, cytokine analysis and flow cytometry.
Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…
In vivo pharmacology CRO near Philadelphia running a broad catalog of efficacy models across CNS, pain, metabolic and inflammatory disease.
Integrated discovery and development services company in India offering in vivo pharmacology, DMPK, bioanalysis and safety assessment alongside chemistry and biologics services.
Korean non-clinical CRO focused on efficacy testing of new drug candidates, with research facilities in Songdo, Incheon.
Bengaluru CRDMO offering discovery services including DMPK, safety and bioanalysis alongside development and manufacturing.
Preclinical CRO in Northern Ireland, part of QIMA Life Sciences, running non-GLP rodent PK, dose range finding, biodistribution and disease model studies.
Translational research company using Old World primate models for ophthalmology, CNS and metabolic disease studies, with an AAALAC-accredited primate facility.
San Diego oncology CRO offering patient-derived and orthotopic tumor models for in vivo efficacy and translational studies.
Preclinical oncology and immuno-oncology CRO with orthotopic and metastatic models, whole-body imaging and GLP toxicology, with sites in Australia and the US.
OHSU national primate research center supporting neuroscience, metabolic, reproductive and infectious disease research, with core services available to outside investigators.
French preclinical CRO specializing in bone, joint and inflammatory disease models with histology and imaging readouts.
French neuroscience CRO offering in vitro and in vivo models for neurological and neurodegenerative drug discovery.
Ophthalmology-focused preclinical CRO offering ocular efficacy models, formulation screening, ocular PK and tolerability studies.
German DMPK CRO offering in vitro ADME, in vivo pharmacokinetics and bioanalysis for discovery and early development.
Independent nonprofit research institute with a national primate research center and high-containment labs, offering contract infectious disease, vaccine and NHP studies.
Shanghai oncology CRO with patient-derived xenograft and other tumor models for efficacy studies.
Swedish CRO specializing in rodent models of arthritis, autoimmunity and inflammation.
Bay Area preclinical CRO offering GLP and non-GLP toxicology, pharmacology and efficacy models with an in-house histopathology lab, including tissue cross-reactivity and histomorphometry.
Korean CRO covering GLP toxicity, PK and efficacy studies through to clinical trials for drugs, devices and other products.
Nonprofit mouse genetics institute offering contract in vivo pharmacology using its own strains and humanized and PDX models across oncology, neuroscience, metabolism and immunology.
Japanese preclinical CRO offering GLP safety and efficacy studies for drugs, devices and regenerative products, with long minipig experience.
Specialty preclinical CRO focused on hearing research, offering ototoxicity, otoprotection and auditory efficacy studies.
Edmonton CRO providing anti-infective drug discovery support, including in vivo infection models and pharmacokinetics.
Houston preclinical CRO near the Texas Medical Center with an AAALAC-accredited mouse vivarium, in vivo pharmacology and flexible lab space.
Southwest China pharmacology CRO specializing in nonhuman primate efficacy, PK/PD and exploratory safety studies.
French preclinical CRO offering in vivo pharmacology in neuroscience, pain and dermatology, plus related safety studies.
French translational oncology CRO built around patient-derived xenograft models, with drug response and biomarker discovery services.
Independent Danish CRO focused on early in vivo pharmacology in rodents, with particular expertise in mouse cancer and immuno-oncology models.
GLP-accredited preclinical CRO headquartered in Denmark with sites in Sweden, Austria and the UK. Known for Gottingen minipig work and regulatory toxicology, with discovery pharmacology including CNS and…
Indian integrated drug discovery CRO offering in vivo pharmacology and DMPK alongside chemistry and biology.